Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR_based lipoprotein profiling.

[1]  V. Wong,et al.  A new definition for metabolic associated fatty liver disease: an international expert consensus statement. , 2020, Journal of hepatology.

[2]  Luca Valenti,et al.  Update on NAFLD genetics: from new variants to the clinic. , 2020, Journal of hepatology.

[3]  N. Lundbom,et al.  Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids. , 2019, JCI insight.

[4]  Jonathan C. Cohen,et al.  PNPLA3, CGI‐58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice , 2019, Hepatology.

[5]  H. Völzke,et al.  The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort. , 2017, Journal of hepatology.

[6]  Jonathan C. Cohen,et al.  Adiposity Amplifies the Genetic Risk of Fatty Liver Disease Conferred by Multiple Loci , 2017, Nature Genetics.

[7]  The prevalence of multiple non-communicable diseases among middle-aged and elderly people: the Shanghai Changfeng Study , 2017, European Journal of Epidemiology.

[8]  Jonathan C. Cohen,et al.  Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins* , 2016, The Journal of Biological Chemistry.

[9]  Anne Tybjærg-Hansen,et al.  Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease , 2014, Nature Genetics.

[10]  Michael Charlton,et al.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. , 2012, Gastroenterology.

[11]  Meng-Su Zeng,et al.  Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method , 2011, Obesity.

[12]  A. Hofman,et al.  The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design , 2010, European Journal of Epidemiology.

[13]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.